China approves Sinovac Biotech Covid-19 vaccine for general public use, East Asia


Source: straitstimes.com straitstimes.com

Key Topics in this News Article:

News Snapshot:

BEIJING (REUTERS) - Sinovac Biotech said on Saturday (Feb 6) that its unit's Covid-19 vaccine has been formally approved for use by the general public by China's medical products regulator. Prior to the approval, the CoronaVac vaccine had already been administered in China's vaccination programme mainly targeting key groups deemed to be at higher risk of exposure to the virus. This story is developing. More on this topic Related Story Sinovac says Covid-19 vaccine effective in preventing hospitalisation, death Related Story Interactive: Tracking the Covid-19 vaccine race